Teva/Allergan acquisition: Commission conditional approval | Practical Law

Teva/Allergan acquisition: Commission conditional approval | Practical Law

The European Commission has approved the proposed acquisition of the generics business of Allergan plc by Teva, subject to conditions.

Teva/Allergan acquisition: Commission conditional approval

Practical Law UK Articles 7-627-0501 (Approx. 2 pages)

Teva/Allergan acquisition: Commission conditional approval

by Clifford Chance LLP
Published on 28 Apr 2016European Union, United Kingdom
The European Commission has approved the proposed acquisition of the generics business of Allergan plc by Teva, subject to conditions.